Second, JapA selectively inhibits breast cancer cell growth, reduces the cell colony formation and proliferation, arrests cells in the G2/M phase, and induces apoptosis through an MDM2-dependent mechanism, independent of p53 status. Here, MDM2 is linked to breast cancer.